- Trials with a EudraCT protocol (39)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
39 result(s) found for: Alveolar bone.
Displaying page 1 of 2.
| EudraCT Number: 2005-004392-38 | Sponsor Protocol Number: R050187 | Start Date*: 2006-01-12 |
| Sponsor Name:NHS Greater Glasgow/Glasgow University | ||
| Full Title: The feasibility of using Bone Morphogenetic Protein (rhBMP-7) for reconstruction of alveolar cleft | ||
| Medical condition: Autogenous bone graft harvested from the iliac crest is utilised as a gold standard for alveolar reconstruction. However, the harvesting of the bone graft is associated with morbidity which could ... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-002370-23 | Sponsor Protocol Number: CL2-12911-039 | Start Date*: 2011-11-30 | ||||||||||||||||
| Sponsor Name:INSTITUT DE RECHERCHES INTERNATIONALES SERVIER | ||||||||||||||||||
| Full Title: A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelli... | ||||||||||||||||||
| Medical condition: Dental implantation in osteoporotic patients or in patients at risk of osteoporotic fracture. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: IT (Prematurely Ended) DE (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2015-001434-16 | Sponsor Protocol Number: 3D_CHB/collacone | Start Date*: 2016-03-30 | |||||||||||
| Sponsor Name:Universitätsmedizin Greifswald, KöR | |||||||||||||
| Full Title: A method for measuring volume changes of the alveolar ridge during dental implantation using 3D scanning | |||||||||||||
| Medical condition: alveolar ridge atrophy | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-001167-75 | Sponsor Protocol Number: FIBEA-04-EC-19-ALV | Start Date*: 2019-09-09 |
| Sponsor Name:BTI I MAS D | ||
| Full Title: Randomized Clinical Trial, conventional treatment-controlled, studying the efficacy of Plasma Rich in Growth Factor (PRGF®) in alveolar ridge preservation after simple exodontia in the anterior reg... | ||
| Medical condition: Alveolar ridge preservation after exodontia of uniradiculate dental pience in the anterior region of maxilla | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-001655-31 | Sponsor Protocol Number: AL3818-US-004 | Start Date*: 2017-12-20 | |||||||||||||||||||||
| Sponsor Name:ADVENCHEN LABORATORIES, LLC | |||||||||||||||||||||||
| Full Title: A Phase III Study of AL3818 (Anlotinib) Hydrochloride Monotherapy in Subjects with Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma | |||||||||||||||||||||||
| Medical condition: Metastatic or advanced alveolar soft part sarcoma, leiomyosarcoma and synovial sarcoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: IT (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2007-005017-19 | Sponsor Protocol Number: BO20924 | Start Date*: 2008-06-17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:F. Hoffmann-La Roche Ltd | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: Open-label, multi-center, randomized, phase II study evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients presenting with metastatic rhabdomyosarcoma and non-... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Patients aged 6 months to <18 years, presenting with metastatic rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcoma. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GB (Completed) FR (Completed) NL (Completed) IT (Completed) BE (Completed) ES (Completed) PL (Completed) DE (Completed) CZ (Completed) Outside EU/EEA | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2021-005511-32 | Sponsor Protocol Number: XEOLAS | Start Date*: 2022-09-12 |
| Sponsor Name:Xeolas Pharmaceuticals Ltd. | ||
| Full Title: A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Study to confirm the Efficacy and Safety of “Effects of topical Alendronic Acid on alveolar bone remodeling af... | ||
| Medical condition: Healthy patients periodontal disease, that qualify for oral surgery of the alveolar bone(ASA I and II) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-003745-18 | Sponsor Protocol Number: GISG-04 | Start Date*: 2012-05-22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:University of Heidelberg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: A PHASE II WINDOW-OF-OPPORTUNITY STUDY OF PREOPERATIVE THERAPY WITH PAZOPANIB (VOTRIENT®) IN HIGH-RISK SOFT TISSUE SARCOMA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: High-risk soft tissue sarcoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2021-005374-26 | Sponsor Protocol Number: ECAELEV21 | Start Date*: 2022-08-18 |
| Sponsor Name:OMEQUI coordinator | ||
| Full Title: Efficacy of platelet- and leukocyte-rich fibrin (L-PRF) in reducing healing time in sinus lift combined with deproteinized bovine mineralized bone (DBBM): randomized clinical trial. | ||
| Medical condition: If the application of L-PRF with respect to the use of DBBM shows that there are differences in the percentage of new bone between the LPRF group and the control group at 4 and 6 months | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-004493-34 | Sponsor Protocol Number: 2017/06NOV/503 | Start Date*: 2018-01-02 |
| Sponsor Name:Cliniques universitaires Saint-Luc | ||
| Full Title: Evaluation of multiple subgingival irrigations with 10% povidone iodine after scaling and root planing : a randomized clinical trial | ||
| Medical condition: Periodontitis is characterized by alveolar bone loss induced by the host immune response to bacterial insult. Because povidone iodine is known to be a powerful antiseptic, there is biologic rationa... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-001068-39 | Sponsor Protocol Number: ECPAF11/16 | Start Date*: 2018-07-24 |
| Sponsor Name:OMEQUI | ||
| Full Title: Changes in the bone morphology of the post-extraction socket, preserved with platelet-rich fibrin and leukocytes (L-PRF) versus Conventional treatment | ||
| Medical condition: Regenerative potential of L-PRF | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-001227-39 | Sponsor Protocol Number: 779322 | Start Date*: 2019-12-11 | |||||||||||
| Sponsor Name:University of Bergen, Faculty of Medicin, Department of Clinical Dentistry | |||||||||||||
| Full Title: A randomized controlled clinical trial to assess the efficacy of a combination of autologous mesenchymal stem cells and biomaterial in jaw bone regeneration prior to dental implant placement in com... | |||||||||||||
| Medical condition: Patients in need of dental implant(s) in the upper and lower jaws with presence of bone defects with loss in vertical height and < than 4 mm in lateral width | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) NO (Completed) ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-003551-20 | Sponsor Protocol Number: 2006-MSC-01 | Start Date*: 2007-06-25 |
| Sponsor Name:Department of Oral Surgery Dental School Med. Univ. Graz, Austria | ||
| Full Title: The Effect of adult MSC on Bone Regeneration and Osseointegration of Dental Implants following a Sinus Augmentation Procedure | ||
| Medical condition: In patients with biltareral edentulous areas and resorbed alveolar processes in the maxilla a bilateral sinus augmentation with Bio-OssTM, CE certified (Geistlich Biomaterials, Wolhusen Switzerlan... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-001972-55 | Sponsor Protocol Number: 20963.091.08 | Start Date*: 2009-09-30 |
| Sponsor Name:UMC St Radboud | ||
| Full Title: Efficacy of hyperbaric oxygen therapy in the treatment of late radiation damage, osteoradionecrosis, of the lower jaw. | ||
| Medical condition: Osteoradionecrosis of the jaw due to previous radiotherapy treatment in the head and neck region | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-001853-15 | Sponsor Protocol Number: NL61830 | Start Date*: 2018-07-11 |
| Sponsor Name:Leiden University Medical Center | ||
| Full Title: An explorative study for halting inflammation in patients with emphysema by intravenous administration of autologous bone marrow derived mesenchymal stromal cells. | ||
| Medical condition: Pulmonary emphysema | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004046-41 | Sponsor Protocol Number: 273551 | Start Date*: 2021-12-09 |
| Sponsor Name:University of Bergen, | ||
| Full Title: A multicentre clinical trial; Alveolar bone augmentation using Mesenchymal Stem Cells and biphasic calcium phosphate granules prior to dental implants | ||
| Medical condition: Patients in need of dental implant(s) in the upper and lower jaws with presence of bone defects with loss in vertical height and < than 4 mm in lateral width | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-001988-52 | Sponsor Protocol Number: 90101 | Start Date*: 2012-07-30 | ||||||||||||||||||||||||||||||||||||
| Sponsor Name:EORTC | ||||||||||||||||||||||||||||||||||||||
| Full Title: Cross-tumoral Phase 2 clinical trial exploring Crizotinib (PF-02341066) in patients with advanced tumours induced by causal alterations of either ALK or MET. | ||||||||||||||||||||||||||||||||||||||
| Medical condition: Locally advanced and/or metastatic malignant tumor (anaplastic large cell lymphoma, inflammatory myofibroblastic tumor, papillary renal cell carcinoma type 1, alveolar soft part sarcoma, clear cell... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
| Trial protocol: BE (Completed) DE (Completed) GB (GB - no longer in EU/EEA) AT (Completed) NL (Completed) FR (Completed) NO (Completed) SI (Prematurely Ended) IT (Completed) PL (Completed) DK (Prematurely Ended) SK (Completed) | ||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2020-001939-27 | Sponsor Protocol Number: SystABSinus01 | Start Date*: 2021-02-25 |
| Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Zahn-, Mund- und Kieferheilkunde | ||
| Full Title: The effect of systemic antibiotics on post-surgical complications and patient-centered outcomes in patients undergoing implant surgery with guided bone regeneration and simultaneous sinus floor ele... | ||
| Medical condition: patients undergoing oral implant therapy with simultaneous lateral sinus floor elevation and guided bone regeneration (GBR) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-001885-40 | Sponsor Protocol Number: Syst-AB+Sinus | Start Date*: 2022-02-24 |
| Sponsor Name:Universidad Complutense de Madrid | ||
| Full Title: The effect of systemic antibiotics on post-surgical complications and paitent-centered outomes in patients undergoing implant surgery with the guided bone regeneration and simultaneous sinus floor ... | ||
| Medical condition: The medical condition that the patients have in this trial is edentulism in a posterior maxillary quadrant of the mouth with a sinus pneumatisation/ decreased crestal bone heigh defect requiring a... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-005294-60 | Sponsor Protocol Number: CRAD001C24114 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Novartis Pharma GmbH | |||||||||||||
| Full Title: Multicenter, triple-arm, single-stage, phase II trial to determine the preliminary efficacy and safety of RAD001 in patients with histological evidence of progressive or metastatic bone or soft tis... | |||||||||||||
| Medical condition: histological evidence of progressive or metastatic bone or soft tissue sarcomas | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
